Mature recirculating B cells are generally assumed to exist in follicular niches in secondary lymphoid organs, and these cells mediate T-dependent humoral immune responses. We show here that a large proportion of mature B lymphocytes occupy an anatomically and functionally distinct perisinusoidal niche in the bone marrow. Perisinusoidal B cells circulate freely, as revealed by parabiosis studies. However, unlike their counterparts in the follicular niche, these cells are capable of being activated in situ by bloodborne microbes in a T-independent manner to generate specific IgM antibodies. The bone marrow represents a unique type of secondary lymphoid organ in which mature B cells are strategically positioned in the path of circulating microbes.
Introduction
The bone marrow is the primary site of B cell generation after birth (Rajewsky, 1996; Nunez et al., 1996) A recirculating lymphocyte enters a secondary lymphoid organ in search of antigen and then, in the absence of specific antigen, leaves for other secondary lymphoid organs. While our two-photon experiments establish that B cells rapidly enter the bone marrow, direct evidence has not been provided that they leave this site. The most direct interpretation of our parabiosis experiments is to infer that mature B cells must constantly emerge from the bone marrow apart from entering it from the blood, in order for equivalence of bone marrow B cells from both partners to be achieved. However, it is formally possible that mature B cells enter from the blood and never leave the bone marrow, but turn over rapidly in this organ and therefore need to be constantly replenished. This sort of rapid replenishment from the circulation could also, in theory, lead to the equivalent distribution of mature B cells from host-and partner-derived populations in parabiosis experiments. In order to address this possibility, we have used BrdU labeling and decay, over a 7 week period, to compare the life spans of mature B cells in the bone marrow and the spleen. As seen in Figure 3D 
Activated B Cells Are Induced in the Bone Marrow by Blood-Borne Microbes
Although the bone marrow functions as a primary lymphoid organ, it may also potentially serve as a secondary lymphoid organ for the induction of humoral immunity. Given the vascularity of the bone marrow and the strategic location of perisinusoidal B cells, we considered the possibility that these B cells might be activated by blood-borne microbes, particularly microbes with a known propensity for the bone marrow. In order to further establish that the bone marrow is functionally a secondary lymphoid organ, we challenged mice intra- , 1996) . We noted that intravenously injected S. typhimurium accesses the spleen and bone marrow but does not readily access lymph nodes ( tion. The bacterium was not found in mesenteric lymph nodes (0 cfus; the assay has a detection limit of 2 cfus).
In order to establish that perisinusoidal B cells do respond in situ to microbes, we decided to look for activated B cells in the bone marrow itself, very soon after microbial challenge. It is now recognized that many T-independent responses can result in the formation of B cell clusters made up of activated CD45 + PNA + B cells (Manser, 2004) , although cells with these phenotypes are more frequently described in germinal centers during T-dependent immune responses. As seen in Figure  4A knockout homozygotes ( Figure 5A ) that lack all T cell populations. Activated B cells were readily observed, albeit to a slightly lesser extent in the bone marrow, in the absence of any T cells, indicating that perisinusoidal B cells may be activated even in the absence of T cell help. The possibility that T cells can also contribute to B cell activation in the bone marrow cannot be excluded. The activated B cell phenotype seen on flow cytometry in the bone marrow is consistent with the activation phenomenon that is observed in responses to some T-independent antigens, in the absence of concomitant isotype switching and somatic mutation (Manser, 2004) . Perisinusoidal B cells in the bone marrow may be uniquely situated to encounter and respond to certain blood-borne pathogens that tend to enter and colonize this compartment.
We wished to establish that the activated B cells seen were generated in situ and did not represent cells that had migrated from the spleen to the bone marrow. We considered examining the bone marrows of splenectomized Aly mice (which lack NIK, an NFκB-activating kinase). These mice lack lymph nodes but are not suitable for our studies because B cells that lack NIK cannot be readily activated (Yamada et al., 2000) . We therefore splenectomized wild-type mice and challenged them intravenously with the vaccine strain of S. typhimurium. As can be seen in Figure 5B , bone marrow B cells were readily activated in mice whose spleens had been removed. These data suggest that blood-borne microbes may induce the activation of B cells in the bone marrow and that this activation almost certainly represents an in situ response.
We wished to ask whether the CD45R + PNA + B cell population that we observed in the bone marrow was derived from mature bone marrow B cells as we pre- is not known at present, though it might be speculated that T-dependent germinal center phenotype B cells (from the spleen) survive better than their bone marrow counterparts that might have been activated in a T-independent manner.
T-Independent Induction of IgM AFCs in the Bone Marrow
Our studies have established that activated B cells may be generated in the bone marrow in response to intravenous injection of S. typhimurium and that this activation event occurs in splenectomized mice in the absence of T cells. While these activated B cells are capable of quite rapidly contributing to IgM secretion in recipient mice, we also wished to establish whether anti-Salmonella IgM-secreting antibody-forming cells were generated in the bone marrow following vaccination.
We used an ELISPOT approach to identify antibodyforming cells that secrete anti-Salmonella IgM antibodies, in both the spleen and the bone marrow, in wild-type mice before and after splenectomy and in TCRβ/δ double knockout homozygotes. Since bloodborne S. typhmiurium lodges preferentially in the spleen and bone marrow (Table 1) , we also chose to examine bone marrow anti-Salmonella IgM antibody secretion in wild-type mice after splenectomy, in order to rule out migration of activated B cells from the 
Surgical Procedures
Parabiosis was performed as described (Bunster and Meyer, 1933). C57BL/6 (CD45.2) mice were united to B6.SJL (CD45.1) mice, and C57BL/6-TgN (ACTβEGFP)1Osb were united with C57BL/6 mice. Parabiosis was well tolerated, and the mice were active over the period of study. Splenectomy was performed following standard surgical procedures.
Bromodeoxyuridine Labeling and Chase

Continuous labeling with BrdU was performed as described earlier (Cariappa et al., 1999).
Bacterial Challenge Studies 0.5 × 10 6 bacteria derived from an overnight culture of S. typhimurium strain SL3261 (Hormaeche et al., 1996) were injected intravenously into mice housed in a BL2 facility. For determination of colony-forming units, bone marrow, splenic, and lymph node cells were lysed in sterile 1% Triton X-100. Serial dilutions of the lysates were made in PBS and plated on LB agar. Colonies were counted after overnight incubation at 37°C and the number of cfu per million cells calculated. For organ colony counts, the same procedure was used after creating single-cell suspensions.
RT-PCR
Standard methods were used to prepare total cellular RNA and first-strand cDNA from flow-purified cells. The following primers (5#-3#, forward followed by reverse) were used in the PCR: hypoxanthine guanine phosphoribosyltransferase (HPRT), GCTGGTGAA AAGGACCTCT and CACAGGACTAGAACACCTGC; and activationinduced cytidine deaminase (AID), GAGGGAGTCAAGAAAGTCACGC and GGCTGAGGTTAGGGTTCCATCT. The AID primer sequences were adapted from previously published reports (Muramatsu et al., 1999) . 6 based on an average total PBMC count of 3.2 × 10 6 and a total blood volume of 1.5 ml in a mouse weighing 20 g. This absolute PBMC value was used to calculate absolute numbers in each of the peripheral blood B cell fractions.
Curve Fitting
For the BrdU decay data points, curves of best fit by the least squares method were generated using MacCurveFit 1.5 (Kevin Raner Software, Australia).
Statistical
Analysis p values for differences between groups was determined by the Mann-Whitney U test using StatView version 5.0.1.
Supplemental Data
Supplemental Data include two figures and two movies and can be found with this article online at http://www.immunity.com/cgi/ content/full/23/4/397/DC1/.
